Advances in Predictive Biomarkers for Immune Checkpoint Inhibitors in Lung Cancer: Why, Who, and How

Review this program to get up to date on the latest data informing optimal integration of immunotherapy biomarkers into the management of patients with lung cancer, including an on-demand Webcast capturing discussion by medical oncology and pathology experts from a symposium at the 2019 Clinical Pathology meeting and downloadable slidesets.
Hossein Borghaei, MS, DO
Program Director
H. Jack West, MD
Program Director
Joshua Bauml, MD
Sanjay Mukhopadhyay, MD
Sandip P. Patel, MD

Downloadable Slidesets

Download this slideset to review the latest clinical data supporting the optimal use of biomarker testing for checkpoint inhibitor therapy in patients with advanced NSCLC, unresectable stage III NSCLC, or extensive-stage SCLC.

H. Jack West, MD
Program Director
Joshua Bauml, MD Sandip P. Patel, MD
Released: November 5, 2019

Download this slideset to review expert guidance on optimal biomarker testing in lung cancer, including molecular testing by NGS and PD-L1 testing to predict response to checkpoint inhibitor–based therapy.

Sanjay Mukhopadhyay, MD Released: November 5, 2019

Download this slideset to gain expert insights on promising new biomarkers predicting response to checkpoint inhibitors in lung cancer, including thoughts on TMB, MSI, and immunogenic neoantigen burden.

Hossein Borghaei, MS, DO
Program Director
Sandip P. Patel, MD
Released: November 5, 2019

CME/MOC-Certified On-Demand Webcast

Watch this CME/MOC-certified on-demand Webcast of a CCO symposium at ASCP 2019 to gain insights from both medical oncology and pathology experts on the optimal use of predictive biomarkers for immune checkpoint inhibitors in the care of patients with lung cancer.

H. Jack West, MD
Program Director
Sanjay Mukhopadhyay, MD Sandip P. Patel, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit US Physicians: maximum of 1.0 Medical Knowledge MOC point(s) Released: October 8, 2019 Expired: No longer available for credit
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AstraZeneca
Bristol-Myers Squibb
Genentech
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue